|
CDK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.59250000000932E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.052750E-01 |
| Normal-vs-Stage2 |
2.115600E-01 |
| Normal-vs-Stage3 |
2.001600E-04 |
| Normal-vs-Stage4 |
7.296400E-03 |
| Stage1-vs-Stage2 |
5.269600E-01 |
| Stage1-vs-Stage3 |
9.93219999999573E-05 |
| Stage1-vs-Stage4 |
2.303800E-03 |
| Stage2-vs-Stage3 |
4.164200E-02 |
| Stage2-vs-Stage4 |
4.559500E-02 |
| Stage3-vs-Stage4 |
7.711800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.441300E-04 |
| Normal-vs-AfricanAmerican |
1.016350E-02 |
| Normal-vs-Asian |
4.104200E-02 |
| Caucasian-vs-AfricanAmerican |
8.580200E-01 |
| Caucasian-vs-Asian |
3.355000E-01 |
| AfricanAmerican-vs-Asian |
1.877030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.188000E-04 |
| Normal-vs-Female |
1.043150E-03 |
| Male-vs-Female |
3.654200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.028430E-02 |
| Normal-vs-Extreme_Weight |
5.733600E-02 |
| Normal-vs-Obese |
1.458460E-03 |
| Normal-vs-Extreme_Obese |
7.362600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.541000E-01 |
| Normal_Weight-vs-Obese |
6.071200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.917800E-03 |
| Extreme_Weight-vs-Obese |
4.092400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.614300E-02 |
| Obese-vs-Extreme_Obese |
1.578650E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.875900E-03 |
| Normal-vs-Age(41-60Yrs) |
8.04240000000789E-05 |
| Normal-vs-Age(61-80Yrs) |
2.060100E-02 |
| Normal-vs-Age(81-100Yrs) |
3.525800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.108100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.483200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.311990E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.515200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.080000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.747800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.336210E-01 |
| Normal-VS-Type2 PRCC |
7.612200E-04 |
| Normal-VS-KIRP CIMP |
3.605900E-04 |
| Normal-VS-Unclassified PRCC |
1.902500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.455100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.417100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.926400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.059490E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.568800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.026500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.528400E-02 |
| Normal-vs-N1 |
2.04530000003089E-06 |
| Normal-vs-N2 |
1.518990E-01 |
| N0-vs-N1 |
1.235600E-04 |
| N0-vs-N2 |
6.279600E-02 |
| N1-vs-N2 |
6.300000E-01 |
|
|
